The QualityStocks Daily Monday, June 24th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (ADAC) +66.67%

StockMarketWatch (PCMI) +42.90%

NetworkNewsWire (SHRG) +28.06%

The QualityStocks Daily Stock List

Stereotaxis, Inc. (STXS)

NetworkNewsWire, InvestorVillage, Market Memory, Marketbeat, Zacks, EarningsCast, Equity Clock, MarketWatch, Insider Financial, The Street, Stockhouse, and Insider Tracking reported previously on Stereotaxis, Inc. (STXS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stereotaxis, Inc. is the international leader in inventive robotic technologies for the treatment of cardiac arrhythmias. The design of these robotic technologies are to enhance the treatment of arrhythmias and perform endovascular procedures. The Company’s mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. Based in St. Louis, Missouri, Stereotaxis lists on the OTC Markets Group’s OTCQX.

Greater than 100 issued patents support the Stereotaxis platform. The Company’s core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, and networking and patient information management systems, and the Vdrive™ robotic navigation system and consumables, which have received regulatory clearance in the U.S., the EU, Japan, Canada, China, and elsewhere. Stereotaxis Imaging Model S is CE marked and Food and Drug Administration (FDA) cleared. Stereotaxis’ innovations help physicians provide premier patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Benefits of the Niobe® Robotic Magnetic Navigation System include unprecedented catheter precision & reach; and stable focal contact in a beating heart. Benefits also include improved physician safety & enhanced skill; and improved patient safety & outcomes.

Stereotaxis and Osypka AG announced a wide-ranging strategic collaboration this past May. Stereotaxis and Osypka are designing and developing a next-generation magnetic ablation catheter to be navigated using Stereotaxis’ robotic technology. Stereotaxis is funding the development. The Company will be the sole owner of the catheter. Osypka is a pioneer in electrophysiology and a leading manufacturer of interventional products.

Stereotaxis recently introduced Stereotaxis Genesis RMN, the next-generation robotic platform and a significant advancement in robotic magnetic navigation technology. The Stereotaxis Genesis RMN system provides the established benefits and reliability of robotic magnetic navigation in a highly unique architecture that is quicker, smaller, lighter and more flexible.

Last week, Stereotaxis announced the first graduating class from the Company’s Robotic Electrophysiology Fellows Program. The design of the Robotic Electrophysiology Fellows Program is to enhance the traditional electrophysiology fellowship by facilitating mastery of robotic magnetic navigation, fostering a worldwide community of the future leaders in the field, and providing fellows with a differentiated and specialized skillset as they advance their medical careers. Formed in 2018, the Robotic Electrophysiology Fellows Program presently is active at 18 leading medical centers around the world and has enrolled 34 electrophysiology fellows.

Stereotaxis, Inc. (STXS), closed Monday's trading session at $2.75, up 1.85%, on 60,605 volume with 63 trades. The average volume for the last 3 months is 89,092 and the stock's 52-week low/high is $0.70/$2.90.

chart

General Cannabis Corp. (CANN)

Daily Marijuana Observer, Stockhouse, YCharts, Infront Analytics, Insider Financial, CannabisMarketCap, Micro Small Cap, Micro Cap Daily, OTC Markets, StreetWise Reports, Pot Stock Watch, Pot Stock News, Zacks, The Street, Green Rush Review, and Simply Wall St reported previously on General Cannabis Corp. (CANN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

General Cannabis Corp. is the comprehensive national resource to the regulated cannabis industry. The Company is a trusted partner to the cultivation, production and retail sides of the cannabis business. It was previously known as Advanced Cannabis Solutions, Inc. It changed its name to General Cannabis Corp. in June 2015. General Cannabis has strong operating divisions including real estate, consulting, security, financing and the distribution of vital infrastructure products to grow facilities and dispensaries. OTCQX-listed, General Cannabis is based in Denver, Colorado.

General Cannabis’ family of brands includes Next Big Crop (NBC); Chiefton; and Iron Protection Group (IPG). Next Big Crop (NBC) offers first-rate management and consulting services. NBC deploys proven solutions for every phase of medical and adult-use cannabis business operations. This is from licensure, design and construction, to the cultivation, manufacture and sale of medical-grade cannabis product.

Chiefton works to provide eco-friendly apparel, accessories, and printing techniques. Chiefton’s apparel and accessories use textiles such as hemp, organic cotton, and recycled polyester. These deliver performance, comfort, and accountability. Also, Chiefton utilizes Denver’s only certifiably green screen-printing shop.

Iron Protection Group (IPG) is one of the fastest-growing security companies in the nation. IPG’s operators are U.S. Veterans. They are vigilant about education regarding regulations in order to ensure that compliance infuses every aspect of its clients’ businesses. General Cannabis’ brands also include GC Capital (Capital Investments Real Estate); Next Big Crop (Operations Consultant and Products); and STOA Wellness (Consumer Goods).

Earlier in June, General Cannabis announced that it entered into a non-binding term sheet to acquire substantially all of the assets of The Organic Seed, LLC, doing business as Cannaseur. Cannaseur is a vertically integrated cannabis license holder located in Pueblo West, Colorado. In addition to the Cannaseur dispensary and cultivation facility, the term sheet includes Cannaseur’s infused products line, Dabtek.

Mr. Michael Feinsod, Executive Chairman of General Cannabis, said, “This is what we have been waiting for, the finalization of a legal framework that permits publicly traded companies to own and operate cannabis companies within Colorado. We have been working in Colorado for 6 years, leading the State’s revolution into legalized cannabis sales. Our 85 employees operate within the regulated cannabis industry and we are eager to bring our professional services to the state as an owner and operator. Cannaseur provides a solid base for us to leverage our skillset as HB-1090 is enacted.”

General Cannabis Corp. (CANN), closed Monday's trading session at $0.81, off by 3.57%, on 205,060 volume with 245 trades. The average volume for the last 3 months is 218,006 and the stock's 52-week low/high is $0.78/$4.51.

chart

Aben Resources Ltd. (ABNAF)

StockPulse, StockBeat, Resource Stock Digest, Midas Letter, Stock News Now, Energy and Gold, Barchart, Investing News, Resource World, StreetWise Reports, Dividend Investor, Stockhouse, Wallet Investor, and MarketWatch reported earlier on Aben Resources Ltd. (ABNAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Aben Resources Ltd. acquires, explores, and evaluates mineral properties chiefly in British Columbia, Saskatchewan, and the Yukon, Canada. The Company is developing gold-focused projects in British Columbia’s Golden Triangle region and the Yukon Territory. A junior exploration company, Aben has its flagship 23,000 hectares Forrest Kerr Gold Project in the heart of the Golden Triangle. Aben Resources has its corporate office in Vancouver, British Columbia.

Along with the Forrest Kerr Gold Project, the Company has its Justin Gold Project in the Yukon Territory; the Chico Gold Project in Saskatchewan; and the Selwyn Recce Gold Project in the Northwest Territories. Concerning the Forrest Kerr Gold Project, Aben Resources is acquiring a 100 percent interest in this Project, which is situated along the Forrest Kerr Fault that comprises a 40 km long north-south belt overlying rocks of the Hazelton and Stuhini Groups. These are a complex assemblage of volcanic accumulations with intervening sedimentary sequences that are host to significant gold deposits in the Golden Triangle area.

Aben holds a 100 percent interest in the 7,400-hectare Justin Gold Project. The property is in the southeast Yukon on the Tintina Gold Belt to the immediate southeast of Golden Predator's 3 Aces project. Moreover, Aben Resources and Eagle Plains Resources Ltd. have executed a formal Option Agreement where Aben has the exclusive right to earn an undivided 80 percent interest in the Chico Gold Project, positioned 125 km east of La Ronge, Saskatchewan. Furthermore, the 172,728 hectare Selwyn Recce Project is considered to be prospective for the presence of Carlin-type gold deposits and also carbonate-hosted and sedimentary-exhalative (sedex) style silver-lead-zinc deposits and sediment-hosted copper deposits.

Earlier this month, Aben Resources announced, further to its news release on May 23, 2019, the completion of a 173 line kilometer (km) airborne magnetic survey, which covered the entire Boundary Zone, situated in the central portion of the Forrest Kerr Property. The Boundary Zone has been the principal focus of exploration by Aben Resources since 2016.

The 2 km by 5 km survey covered a large package of gold-bearing rocks from the Hazelton Group, a lithology that hosts a number of polymetallic mineral deposits in the region. The expectation is that the airborne magnetic survey will effectively delineate subsurface geologic structures that are intimately associated to the high-grade gold mineralization earlier discovered at the Boundary Zone.

Additionally, this month, Aben Resources announced, further to its news releases on May 23 and June 6, it began drilling at its 100 percent owned Justin Gold Project in the Eastern Yukon. The 2019 exploration program at Justin will entail 1,350 meters of diamond drilling and 600 meters of Rotary Air Blast drilling (RAB), along with prospect generating field work.

Aben Resources Ltd. (ABNAF), closed Monday's trading session at $0.1999, up 6.56%, on 141,879 volume with 6 trades. The average volume for the last 3 months is 57,795 and the stock's 52-week low/high is $0.079/$0.38.

chart

CBD Life Sciences, Inc. (CBDL)

Emerging Growth, News to Watch, Investors News, OTC Markets, OTC.Watch, Globe Newswire, and Stockopedia reported previously on CBD Life Sciences, Inc. (CBDL), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

CBD Life Sciences, Inc.’s principal focus is to identify, evaluate and acquire undervalued opportunities with the aim of increasing shareholder value. The acquisition of LBC Bioscience, Inc. is the first in the CBD space. The Company is actively searching for additional opportunities within this developing sector. CBD Life Sciences lists on the OTC Markets. The Company is headquartered in Scottsdale, Arizona.

CBD Life Sciences announced this past March, that its wholly-owned subsidiary, LBC Bioscience, finalized the formulization for and is launching an organic - GMO free – CBD (cannabidiol) based anti-aging product line. The product line includes anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. In addition, LBC Bioscience is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line.

LBC Bioscience has also entered into negotiations to distribute its line of products in Japan. The initial order is $250,000. Ms. Lisa Nelson, President & Chief Executive Officer of CBD Life Sciences’ said this past April, “We are very excited about this opportunity to enter the Japanese market. The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market.”

This month, CBD Life Sciences announced that its LBC Bioscience completed the development of a disposable CBD vape-pen. This product is now undergoing final market testing. The anticipation is that it will be available for purchase within the next three to four weeks. LBC Bioscience is positioning itself to be a leader in the specialized CBD + e-cigarette vaping market.

Last week, CBD Life Sciences announced that LBC Bioscience is continuing to experience substantial revenue growth due to the expansion and market acceptance of its product lines. LBC is experiencing growth in retail sales. Moreover, it now being approached to provide ‘white label’ versions of its product lines. LBC Bioscience has developed and is retailing/wholesaling a complete line of cannabidiol based organic products. These include hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for pets.

CBD Life Sciences, Inc. (CBDL), closed Monday's trading session at $0.053, up 59.16%, on 1,135,022 volume with 145 trades. The average volume for the last 3 months is 359,824 and the stock's 52-week low/high is $0.0065/$10.00.

chart

First Vanadium Corp. (FVANF)

Stock Gumshoe, Streetwise Reports, Geology for Investors, The Prospector News, Vanadium Price, Investing News, News to Watch, Metals News, Investors Hangout, Investor Ideas, Junior Mining Network, Resource World, Stockhouse, and Trading View reported earlier on First Vanadium Corp. (FVANF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

First Vanadium Corp. engages in the acquisition, exploration, and development of mineral properties in the United States and Canada. OTCQX-listed, it explores for copper, silver, zinc, and gold minerals. The Company previously went by the name, Cornerstone Metals, Inc. It changed its name to First Vanadium Corp. in September of last year. First Vanadium has its corporate office in Vancouver, British, Columbia.

The Company has an option to earn a 100 percent interest in the Carlin Vanadium Project, situated in Elko County, 6 miles south from the town of Carlin, Nevada on Highway I-80. The Carlin Vanadium Project hosts the Carlin Vanadium deposit that is flat to shallow dipping and at shallow depths with a strike length of roughly 1,800 meters, width averaging 600 meters, and thickness ranging from 15 meters to 50 meters. On February 27, 2019, First Vanadium announced its maiden resource.

Moreover, the Company’s West Jerome Project targets a large scale high grade copper and zinc deposit in Arizona. The West Jerome property comprises roughly five square kilometers of claims on the west side of Freeport McMoran patented lands. The property (a Volcanogenic Sulfide camp) is a high-grade, massive sulfide target positioned 2.4 km south of the past-producing United Verde Mine (33 million tons of 4.36% Cu, 1.53 opt Ag and 0.042 opt Au; 2.9 Billion lbs of copper).

This past April, First Vanadium announced that newly acquired historic data extends the strike length of the Carlin Vanadium deposit a further 300 meters (m) (984 ft) to the south on the Carlin Vanadium property. Two drill holes and two trenches completed by Union Carbide in 1968, situated south of, and beyond the current limit of the mineral resource, reported strong vanadium grades. Hole DDH4 returned an average grade of 0.91% V2O5 across 7.01m (23ft), starting near surface and hole R-128 returned an average grade of 0.51% V2O5 across 13.71m (45ft).

First Vanadium Corp. (FVANF), closed Monday's trading session at $0.289183, off by 4.44%, on 47,062 volume with 23 trades. The average volume for the last 3 months is 67,769 and the stock's 52-week low/high is $0.258/$1.60.

chart

OWC Pharmaceutical Research Corp. (OWCP)

Tip Ranks, InvestorsHub, MarketWatch, PR Newswire, Insider Financial, The Street, Stock Invest, OTC Markets, Promotion Stock Secrets, Street Register, The Profit Buzz, CFN Media Group, Seeking Alpha, Stockhouse, Morningstar, and Cannabis Financial Network News reported previously on OWC Pharmaceutical Research Corp. (OWCP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OWC Pharmaceutical Research Corp. engages in the research and development (R&D) of cannabis-based medical products. The Company provides medical products for the treatment of different medical conditions and/or diseases. These include multiple myeloma, psoriasis, PTSD, migraines, and delivery systems. OTCQB-listed, OWC Pharmaceutical Research is headquartered in Petach Tikva, Israel. One World Cannabis Ltd. is a wholly-owned subsidiary of OWC Pharmaceutical Research.

OWC has entered into research and collaboration agreements with three of the leading research institutions in Israel. These include Sheba Academic Medical Center, one of the top academic hospitals in the Middle East. These agreements serve as the basis for the Company’s clinical trials. They ensure that all of its studies have been, and will continue to be, founded on established research protocols of the U.S. Food and Drug Administration (FDA), Institutional Review Boards, and Independent Ethical Committees. 

    OWC has completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. The technology behind the tablet is protected. It provides for the ingestion of almost any dosage of medical cannabis with a sublingual delivery mechanism, where the compounds are absorbed directly into the patient's blood by way of oral epithelial tissue.

Subsidiary One World Cannabis’ Research Division centers on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of diverse medical conditions. Its Consulting Division’s dedication is to helping governments and companies navigate complex international cannabis regulatory frameworks.

OWC has received the first ever Institutional Review Board (IRB) approval to conduct a safety study for a cannabis-based topical cream with more than 3 percent THC. The Company is conducting a safety study (FDA Phase 1 equivalent) in one of the largest academic hospitals in Israel.

Going forward, OWC Pharmaceutical Research’s comparative safety and efficacy trial for its tablet will be initiated in Q2 of 2019. The expectation is that the duration of this trial will be four months. Additionally, the efficacy trial for the Company’s cannabis cream will be initiated in Q3 of 2019. The duration of this trial is expected to be about 24 months.

Regarding its Multiple Myeloma (cancer therapy) program, OWC successfully completed a dosing study for its proprietary, systemic emulsion delivery system in rats. The Company’s pre-clinical results indicated strong potential of its cannabis-based formulations to kill cancer cell lines and tumors in mice. OWC stated that this important milestone was fundamental to enable the translation of these pre-clinical results into a potential therapy.

                   

OWC Pharmaceutical Research Corp. (OWCP), closed Monday's trading session at $0.0192, up 34.74%, on 7,132,783 volume with 219 trades. The average volume for the last 3 months is 1,098,699 and the stock's 52-week low/high is $0.012/$0.237.

chart

Canarc Resource Corp. (CRCUF)

ShazamStocks, CrushTheStreet, Baby Bulls, FeedBlitz, All Penny Stocks, Research Driven Investor, Future Money Trends, SmallCapVoice, and Stockhouse reported earlier on Canarc Resource Corp. (CRCUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Canarc Resource Corp. is a growth-oriented, gold exploration and mining company listed on the OTCQB. It is currently focusing on advanced Gold and Silver assets located in North America. Canarc Resource has its corporate headquarters in Vancouver, British Columbia. 

  The Company’s core Gold Project asset is the 100 percent owned, past-producing, high-grade New Polaris gold mine project in northwestern British Columbia. Based on an updated NI (National Instrument) 43-101 resource estimate using a 6 gpt gold cutoff grade, the New Polaris property presently contains measured and indicated resources of 519,000 oz gold contained in 1,288,000 tonnes grading 12.5 gpt gold.

New Polaris is the Company’s most advanced gold mine project. New Polaris contains inferred resources totaling 636,000 oz gold contained in 1,628,000 tonnes grading 12.2 gpt gold. It is still open for expansion in other veins and at depth.

  Canarc Resource also has its Windfall Hills gold project.  Windfall Hills is 65 kilometers south of Burns Lake and 90 kilometers northwest of Richfield Ventures’ Blackwater gold discovery in central British Columbia. The Windfall Hills project covers claims totaling 3879 hectares. The Company’s Projects also include Corral Canyon, Hard Cash and Nigel, and The Princeton Gold Property.

Recently, Canarc Resource announced the completion of a 970 line-km airborne magnetic and radiometric survey over the newly acquired 2,090 hectare Hard Cash Gold Property in southwestern Nunavut, Canada. Recently, Canarc Resource entered into an option agreement with Silver Range Resources to acquire a 100 percent interest in Hard Cash. Nunavut is home to two multi-million ounce gold deposits at the operating Meadowbank Mine and the Meliadine Mine now under construction, both owned by Agnico Eagle Mines.

  Mr. Scott Eldridge, Canarc Resource Chief Executive Officer, stated: ''Since identifying Hard Cash late last year as a district scale gold exploration opportunity, Canarc has visited the site, sampled high grade gold in bedrock, signed an option agreement to acquire a 100% interest, completed an aero-geophysical survey, and we plan to drill the initial high priority targets this summer. We are moving expeditiously to execute our new corporate strategy of acquiring and exploring high impact gold discovery projects and de-risking our current core assets in order to create shareholder value.''

Canarc Resource Corp. (CRCUF), closed Monday's trading session at $0.045, up 25.00%, on 15,000 volume with 6 trades. The average volume for the last 3 months is 16,060 and the stock's 52-week low/high is $0.0239/$0.0526.

chart

BioCardia, Inc. (BCDA)

Penny Stock Hub, Journal Transcript, Wallmine, TradingView, Insider Financial, 4-Traders, Investing Note, Penny Stock Tweets, Stockwatch, Stockopedia, Simply Wall St, Marketbeat, and MarketWatch reported previously on BioCardia, Inc. (BCDA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioCardia, Inc. is a leader in the development of complete solutions for cardiovascular regenerative therapies. Its biotherapeutic product candidates in clinical development are CardiAMP® (autologous minimally processed bone marrow cells [a patient’s own cells]) and CardiALLO® (allogenic culture expanded mesenchymal stem cells derived from bone marrow [donor-derived]) cell therapies. A clinical-stage regenerative medicine company and OTCQB-listed, BioCardia is headquartered in San Carlos, California.  

BioCardia’s two therapeutic programs are enabled by its Helix™ transendocardial delivery systems and Morph® vascular access products. These are partnered to enable other promising biotherapeutic programs. Furthermore, the Helix transendocardial delivery system is being used by a number of clinical partners in biotherapeutic clinical trials.

The Helix transendocardial delivery system is the leading percutaneous catheter delivery system for cardiovascular regenerative medicine. Helix enables the local delivery of cell and gene-based therapies to treat heart failure, myocardial infarction, ischemia, as well as cardiac conduction disorders.

The Company’s CardiALLO utilizes younger universal donor mesenchymal stem cells. BioCardia states that CardiALLO may be suitable for patients who are not optimal candidates for the CardiAMP therapy. CardiAMP harnesses the potential of autologous minimally processed bone marrow cells, using a companion diagnostic to identify patients most likely to benefit from the therapy. The design of the investigational CardiAMP cell therapy system is to deliver a high dose of a patient’s own bone marrow cells directly to the area of cardiac dysfunction to stimulate the body’s natural healing mechanism after a heart attack.

This past November, BioCardia announced positive 12 month data for the roll-in cohort of its pivotal CardiAMP™ Heart Failure Trial studying the investigational CardiAMP Cell Therapy System in adult patients experiencing heart failure after a heart attack. The results were presented on November 12, 2018, by Peter Johnston, MD, of Johns Hopkins Medical Center at the American Heart Association Scientific Sessions 2018.

The expectation is that the continuing multi-center, double-blinded, randomized (3:2), sham-controlled pivotal CardiAMP Heart Failure Trial will enroll 260 patients at up to 40 centers nationwide. The trial’s primary efficacy endpoint is Six Minute Walk distance at 12 months’ post-treatment, a measure of a patient’s exercise capacity, and incorporates the influence of MACE and other clinically meaningful events.

Recently, BioCardia announced its 510(k) submission for U.S. Food and Drug Administration (FDA) clearance of the AVANCE™ steerable introducer, designed for introducing different cardiovascular catheters into the heart. This includes through the left side of the heart via the interatrial septum.

The AVANCE steerable introducer takes advantage of new technology developed for BioCardia’s Morph family of steerable introducers. It applies it for transseptal procedures. The design of the bidirectional AVANCE is to be virtually whipless around curves, because of its helically arranged pull-wires, and provides excellent torsional stiffness. In addition, AVANCE offers a rotating hemostasis port. The intention of these features is to allow more predictability, stability and control during procedures.

BioCardia, Inc. (BCDA), closed Monday's trading session at $1.24, up 22.17%, on 4,250 volume. The average volume for the last 3 months is 507 and the stock's 52-week low/high is $1.20/$32.22.

chart

Bemax, Inc. (BMXC)

Penny Investor Network, StockRockandRoll, PennyStockLocks, Penny Stock Tweets, Stock Guru, Insider Financial, and ResearchOTC reported on Bemax, Inc. (BMXC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2012, Bemax, Inc. is a growing global distributor of Disposable Baby Diapers. The Company exports and distributes Disposable Baby Diapers from the United States to developing markets in Africa and Europe. In addition, it exports its private label brands from manufacturers in Asia and distributes to other growing markets. Listed on the OTCQB, Bemax is based in Dallas, Georgia.

The Company’s commitment is to the marketing, distribution, and delivery of high quality disposable baby diapers and wipes to respective target markets. Its current emphasis is to supply its clients with disposable baby diapers from manufacturers in North America where quality is superior.

Bemax is pursuing opportunities in the fast-growing international Consumer Staples and Household Products Industries. The Company focuses on business development and mentoring. It synergizes these models into the household products industry.

Bemax announced in 2017 that it entered into a multi-year private labeling agreement with North American Diaper Company (NADC). With this agreement, Bemax will buy, sell, export, and distribute Mother's Touch disposable diapers in private labeled format and in Bemax packaging not trademarked by NADC. NADC is a foremost U.S. manufacturer of value-priced, eco-friendly disposable baby diapers.

Bemax announced this past April that it filed for trademark with the U.S. Patent & Trademark Office (USPTO) for its brand of Mother's Touch disposable diapers. The Company officially filed for trademark on April 28, 2018 (Serial Number 87899104).

Bemax previously announced that its private label brands of sanitary pads and baby wipes would be available for sales commencing this month. The new Bemax private label brands are available on Walmart.com and on bemaxinc.com/webstore.

Shipment of the Company’s new private label brands to wholesalers and distributors started last month. Furthermore, Bemax will extend sales of its private label to other online selling platforms including target.com to support and grow online sales.

Bemax, Inc. (BMXC), closed Monday's trading session at $0.0002, up 100.00%, on 351,000 volume with 4 trades. The average volume for the last 3 months is 13,390,398 and the stock's 52-week low/high is $0.00009/$0.0012.

chart

Dajin Resources Corp. (DJIFF)

Investing News, Stockhouse, Streetwise Reports, Junior Mining Network, InvestorsHub, 4-Traders, GuruFocus, Epstein Research, StockInvest, Barchart, Wall St. Researcher, Wallet Investor, Equities, Marketwired, OTC Markets, TradingView, Investx, Dividend Investor, and MarketWatch reported on Dajin Resources Corp. (DJIFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dajin Resources Corp. is a lithium exploration company listed on the OTC Markets Group’s OTCQB. Via its interest in Dajin Resources S.A. (Dajin S.A.), the Company holds concessions or concession applications in Jujuy Province, Argentina. These were acquired in areas known to contain brines with Lithium, Potassium and Boron values. Dajin Resources has its corporate office in Vancouver, British Columbia.

The aforementioned land holdings exceed 93,000 hectares (230,000 acres). They are mainly located in the Salinas Grandes and Guayatayoc salt lake basins.  Dajin Resources projects include Teels Marsh, Alkali Lake, and Salinas Grandes.

The Teels Marsh Lithium Project in Nevada is 3,202 hectares - 7,914 acres. There are 403 placer claims. Teels Marsh is 100 percent owned by Dajin Resources (US) Corp., which is a wholly-owned subsidiary of Dajin Resources Corp. Construction of drill pads and roads is completed in expectation of starting a drill program later in 2018.

The Alkali Lake Lithium Project in Nevada is 2,262 hectares - 5,591 acres. There are 278 placer claims. Alkali Lake is 100 percent owned by Dajin Resources (US) Corp.

The Salinas Grandes Project in Argentina is 93,000 hectares - 230,000 acres. There are 25 concessions. Salinas Grandes is 100 percent owned by Dajin Resources S. A., which is a wholly-owned subsidiary of Dajin Resources Corp. This past February, Dajin announced the results of 25 shallow brine samples encompassing an area of 550 hectares (5.5 km2) in the northwestern corner of the 4,300-hectare (43 km2) San Jose and Navidad minas.  Concentrations ranged from 281 mg/l to 1,353 mg/l, averaging 591 mg/l Lithium.  A drill program for the San Jose and Navidad minas is now being organized.

Recently, Dajin Resources management reported that the Company’s engineers, Welsh Hagen Associates, Inc. (Reno, Nevada), completed the construction of access roads and drill pads at Dajin’s 100 percent owned, Teels Marsh Lithium brine project in Mineral County, Nevada. Welsh Hagen provided the design, prepared the BLM Notice of Intent and construction services for Dajin.  Tipton Trucking of Mina, Mineral County, Nevada, Coan Equipment and MB America both of Reno, Nevada supplied the construction equipment.

Dajin Resources Corp. (DJIFF), closed Monday's trading session at $0.0354, up 22.069%, on 29,500 volume with 7 trades. The average volume for the last 3 months is 52,041 and the stock's 52-week low/high is $0.025/$0.09.

chart

Adama Technologies Corporation (ADAC)

StreetInsider, InvestorsHub, OTC Markets, Morningstar, and Stockhouse reported on Adama Technologies Corporation (ADAC),  and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Adama Technologies Corporation is a Venture Capital Company listed on the OTCQB. It owns, operates, and invests in technology companies and also startups and expansion companies. The Company has a hands-on approach and works to develop the management and leaders around the corporate landscape to transform big ideas into game changing execution in the field. Adama Technologies has its corporate office in Henderson, Nevada.

Adama Technologies has exceptional access to equity lines of credit, equity funds, private investors, incubators, mentor partners and close ties with Fortune 100, 500 and 1000 companies who serve as exit strategies for many of Adama’s investments.

Adama Technologies’ portfolio companies include Alpine Industries and SafeGuard Pii. Its flagship investment is Alpine Industries located in Utah. Alpine specializes in machining and aerospace manufacturing.

This investment and acquisition launches Adama Technologies into the fast expanding field of aerospace technology. Furthermore, it positions Adama with the stability of being a defense contractor for the U.S. military.

Since its establishment in 1974, Alpine Industries has manufactured several hundred aerospace landing gear components and other spare parts.  It continues to work as a US government contractor.

Presently, Alpine holds more than 15 US Military contracts. Most of these contracts are with the US Air Force. Alpine Industries also manufactures parts for a number of private companies. These include parts for drilling components utilized in oil and water wells, roller-coasters, motorcycles, zip line parts, crash pads, as well as drilling carts.

SafeGuard Pii is an industry pioneer and top-tier Privacy Management Firm. It provides compliance solutions to companies across the United States.  In addition, SafeGuard Pii is the provider of a strong identity theft protection and restoration product.

The Company’s PII Defender program monitors internet black market sites, other internet trading sites where ID thieves buy and sell information, utility and phone records, public databases, criminal databases and DMV records, plus credit files for one’s personal information.

Recently, Adama Technologies announced that it was accepted and successfully up-listed to the OTCQB marketplace with OTC Markets. Adama had outlined a course towards growth and development. This path included development of additional revenue streams, growing revenues within their present operations, and up-listing into the QB Marketplace.

In addition, Adama Technologies recently announced that the Company will bid on an additional $3,000,000 in new government contracts with at least $2,000,000 of that number being for US Military Defense contracts.  Adama detailed its month-of-March bidding plan and strategy and its optimism concerning its ability to win these contracts. As the bidding process is underway, Adama Technologies will continue to look for additional revenue opportunities in its commercial and retail outlets.

Adama Technologies Corporation (ADAC), closed Monday's trading session at $0.0025, up 66.67%, on 137,842 volume with 6 trades. The average volume for the last 3 months is 204,330 and the stock's 52-week low/high is $0.009/$0.18.

chart

NewRange Gold Corp. (NRGOF)

InvestorsHub, Stockhouse, OTC Markets, TheProspectorNews.com, Junior Mining Network, Marketwired, PennyStockHub, Barchart, Stockwatch, OTC Bulls, and First Look Equities reported on NewRange Gold Corp. (NRGOF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

NewRange Gold Corp. concentrates on near to intermediate term production opportunities in favorable jurisdictions, including Nevada, Colorado and Colombia. An exploration and development company, it incorporated in 2006 as Colombian Mines Corporation, dedicated to exploring high quality mineral properties in Colombia.

In July 2016, it diversified into the U.S. through acquiring the high-grade Pamlico gold project in Nevada. OTCQB-listed, NewRange Gold is based in Vancouver, British Columbia. The Company changed its name to Newrange Gold Corp. in December of 2016.

NewRange Gold has its Pamlico Project in Mineral County, Nevada. In Colombia the Company has its El Dovio and Yarumalito projects.

The Pamlico Project is a high-grade epithermal gold system hosted in Jurassic to Tertiary age volcanic and sedimentary rocks. The project encompasses the historic Pamlico Mines on Pamlico Ridge, together with the Central, Sunset, Good Hope, Gold Bar and different unnamed mines and prospects.

Regarding the El Dovio project in Colombia, Newrange Gold holds 100 percent undivided interests in the mineral licenses, which encompass all potential mineralization at El Dovio. The Company purchased 100 percent of the surface rights covering the same ground at El Dovio.

The El Dovio property covers high-grade polymetallic gold-silver-copper-zinc mineralization in a belt of marine volcano-sedimentary rocks known to host other polymetallic and Volcanogenic Massive Sulfide (VMS) prospects and mines.

The Yarumalito Project in Colombia encompasses a large gold dominant porphyry complex composed of multiple intrusive centers. The property covers 1,456 hectares of highly prospective terrain, eleven air kilometers north of the famed Marmato District.

The Company owns a 100 percent undivided interest in the Contract Concession. Moreover, there are no underlying royalties or payments to third parties.

Recently, Newrange Gold announced drill final results for holes P17-33 through P17-40, the last eight holes from the 2017 Pamlico Phase II drill program. Drill holes P17-33, 34 and 35, all contain significant oxide gold intercepts. These confirm and extend high-grade mineralization along the K and J Zones trends within the Merritt target area. Individual samples from these three holes vary up to 56.7 g/T gold (Au). They also continue to highlight broader, lower grade, intervals of near surface bulk tonnage potential.

New Range Gold plans to commence the Phase III drill program this month. The drilling program will test new carbonate (sediment) and volcanic hosted gold targets across the Pamlico property.

Newrange Gold began trading on the OTCQB Venture Market in the United States under the symbol NRGOF effective at the beginning of trading on Wednesday, February 7, 2018.

NewRange Gold Corp. (NRGOF), closed Monday's trading session at $0.1287, up 31.93%, on 850,132 volume with 169 trades. The average volume for the last 3 months is 49,079 and the stock's 52-week low/high is $0.0414/$0.207.

chart

MGT Capital Investments, Inc. (MGTI)

InvestorsHub and OTC Markets reported on MGT Capital Investments, Inc. (MGTI), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

MGT Capital Investments, Inc. ranks as one of the largest U.S.-based Bitcoin miners. The Company’s facility in WA State produces roughly 80 Bitcoins monthly. In addition, MGT continues to focus on an expansion model to grow its crypto assets materially. MGT Capital Investments is based in Durham, North Carolina. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Additionally, MGT Capital Investments is developing a portfolio of cyber security technologies, creating advanced protection technologies for mobile and personal technology devices, and corporate networks. Industry pioneer Mr. John McAfee  is the Company’s visionary leader in this corporate initiative.  

MGT’s first product is named Sentinel. This is an enterprise class network intrusion detector. Sentinel watches one’s network and reacts immediately upon noticing suspicious activity. John McAfee engineered the Sentinel system.

Moreover, the Company has entered into a joint venture (JV) with Nordic IT Sourcing Association Venture Partners. This JV is to develop and market a mobile phone with extensive privacy and anti-hacking features. The tentative release date of the Privacy Phone is February 2018.

MGT Capital Investments is responsible for designing, engineering, as well as testing a state-of-the-art cell phone with privacy features that stay one step ahead of hackers and eavesdroppers. Nordic IT is responsible for sourcing strategic partners to manufacture and assemble the phone. Moreover, Nordic IT is responsible for sales and marketing.

Furthermore, MGT signed a Letter of Intent (LOI) with Bitmain Technologies Limited. This is to form a JV, which will concentrate on opportunities in the Bitcoin space in North America. The proposed JV between MGT Capital Investments and Bitmain Technologies will lead to the development of a state-of-the-art Bitcoin mining pool.

MGT has also entered into a consulting agreement with Future Tense Secure Systems Inc. Future Tense is a technology incubator with investments in other applications requiring privacy, such as file sharing and chat.

Recently, MGT Capital Investments provided an update at its Annual Meeting of Stockholders. It provided an update on its different business initiatives.

Concerning Bitcoin mining activities, Mr. Stephen Schaeffer, President of MGT's Crypto Capital Strategies division, stated in December, "We are ecstatic to report that we have entered into agreements to secure reliable and adequate electric power in Sweden, and expect to begin deployment of mining rigs there by the end of next month.  Moreover, the initial phase of this relationship will give the Company 25 MW of power, enough for over 15,000 Bitmain S-9 mining rigs."

MGT Capital Investments, Inc. (MGTI), closed Monday's trading session at $0.0575, up 36.90%, on 22,125,387 volume with 839 trades. The average volume for the last 3 months is 5,054,291 and the stock's 52-week low/high is $0.028/$1.08.

chart

RedHawk Holdings Corp. (IDNG)

TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, and Hot Stock Profits reported earlier on RedHawk Holdings Corp. (IDNG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.

RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.

Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.  

RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.

EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.

RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.

EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.

RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).

RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S.  RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.

Recently, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.

RedHawk Holdings Corp. (IDNG), closed Monday's trading session at $0.0011, up 22.22%, on 32,412,583 volume with 62 trades. The average volume for the last 3 months is 12,921,697 and the stock's 52-week low/high is $0.0008/$0.0055.

chart

The QualityStocks Company Corner

Willow Biosciences Inc. (CSE: WLLW)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (CSE: WLLW).

Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (CSE: WLLW), closed Monday's trading session at $1.32, even for the day, on 4,775 volume with 12 trades. The average volume for the last 3 months is 42,394 and the stock's 52-week low/high is $1.12/$5.25.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc.’s (OTCQB: PBIO) patented pressure cycling technology (PCT) platform was featured prominently in 15 independent scientific presentations delivered during the annual conference of the American Society of Mass Spectrometry (ASMS) that took place June 1-6, 2019 in Atlanta, Georgia, as the company announced in a recent press release (http://nnw.fm/geA6Y).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Monday's trading session at $2.43, up 1.67%, on 3,827 volume with 12 trades. The average volume for the last 3 months is 8,723 and the stock's 52-week low/high is $1.519/$4.09.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood, Inc. (OTCQB: NGTF), the nationally expanding ice cream company solving America’s $50 billion-dollar nighttime snacking problem, today announced a brand partnership with rock star Michael Clifford, lead guitarist of the multi-platinum, award winning band, 5 Seconds of Summer.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Monday's trading session at $0.4238, up 8.67%, on 145,479 volume with 86 trades. The average volume for the last 3 months is 227,082 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

The technological revolution of the past two decades has reimagined the landscape of social experiences. People have focused a growing measure of time and work on documenting the details of their lives, whether marvelous or mundane, so they can share photos and stories with an expansive network of acquaintances via electronic media platforms. An irony of the reimagined social network is that people may be strongly connected to each other across thousands of miles while virtually unaware of other persons within close physical proximity to them at the same time. Within the social circle revolution, direct sales’ emphasis on personalized shopping experiences has taken on a new degree of importance, as evidenced by the financial strength of direct sales innovator Sharing Services Global Corporation (OTCQB: SHRG) and its homespun Elepreneur network of independent sales associates

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.2049, up 28.06%, on 400 volume with 1 trade. The average volume for the last 3 months is 20,612 and the stock's 52-week low/high is $0.14/$0.39.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) this morning announced its entry into a strategic business cooperation agreement with Fantasy Network Ltd. (TASE: FNTS) of Tel Aviv, Israel. Under the agreement, the companies will form the foundation to joint venture business opportunities in the Israeli medical cannabis sector. To view the full press release, visit http://nnw.fm/Wd05y.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (OTCQB: PNNRF), closed Monday's trading session at $0.1024, up 10.11%, on 2,500 volume with 2 trades. The average volume for the last 3 months is 369 and the stock's 52-week low/high is $0.089/$0.5049.

Recent News

chart

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) today announced its receipt of Health Canada approval for the licensing of 17 additional cultivation rooms within its facility’s Phase 4A/4B perimeter. According to the update, approval of the additional licensed cultivation space increases annual target production capacity to 61,000 kg. "Sustainable growth, exceptional quality and constant innovation are the pillars of our overall strategic approach," Organigram CEO Greg Engel said in the news release. "We are proud to continue to increase our physical capacity to meet the needs of cannabis consumers across the country while also bringing new thinking and technology to our production." To view the full press release, visit http://nnw.fm/hY52I.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $6.29, off by 1.10%, on 775,027 volume with 2,406 trades. The average volume for the last 3 months is 1,005,813 and the stock's 52-week low/high is $2.97/$8.439.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) and its subsidiary Direct Solar’s, Vivint Solar Inc., was featured in a sector snapshot publication from Investorideas.com, examining how continued growth in solar installations in both residential and commercial zones as more businesses and consumers realize the benefits of solar and as it becomes more readily available and affordable for both.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.0152, off by 12.11%, on 9,438,663 volume with 250 trades. The average volume for the last 3 months is 4,506,538 and the stock's 52-week low/high is $0.009/$0.052.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8), a company aiming to create and buy 15 premium brands in California, garnered aggregate gross proceeds of more than C$10 million during its just-closed round of private placement funding, which will be used to fund further equipment purchases for its vertically integrated cannabis facility in Modesto, California, as well as for additional acquisitions and other corporate purposes (http://nnw.fm/vpiN7).

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.

Ecosystem

TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.

The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.

Growing Portfolio

Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.

On Deck

The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.

TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.

Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).

Management

TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.

Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.

Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.

Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

TransCanna Holdings Inc. (CSE: TCAN), closed Monday's trading session at $4.60, off by 5.15%, on 38,074 volume with 47 trades. The average volume for the last 3 months is 153,308 and the stock's 52-week low/high is $0.769/$7.789.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) was featured today in the 420 with CNW by CannabisNewsWire. As plans to legalize marijuana fully appear to have hit a dead end in the New York State legislature, the lawmakers have agreed to expand the decriminalization of the drug in addition to providing for the automatic expungement of low-level cannabis possession convictions across the state.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed Monday's trading session at $2.5001, off by 5.30%, on 186,318 volume with 372 trades. The average volume for the last 3 months is 118,351 and the stock's 52-week low/high is $1.75/$7.3016.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced the launch of its London-based investment platform, Supreme Heights, which is focused on opportunities in the UK and European CBD health and wellness space. To view the full press release, visit http://nnw.fm/LrV4F. Also today, NetworkNewsWire released a report on the company detailing how SPRWF is prepared to meet Health Canada’s amended cannabis regulations, which include three additional types of cannabis products: cannabis edibles, extracts and topicals (http://nnw.fm/9nX51). Furthermore, the company was highlighted in today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $1.17, off by 1.19%, on 238,950 volume with 369 trades. The average volume for the last 3 months is 397,161 and the stock's 52-week low/high is $0.85/$2.039.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) on Friday announced the results of its 2019 annual and special meeting. Held on June 20, 2019, there were 43,217,711 company shares represented in person or by proxy at the meeting, constituting 55.1 percent of Lexaria's issued share capital as of May 3, 2019, the record date of the meeting. The matters voted upon included board member elections, the appointment of Davidson & Company LLP as auditors, approval of the company’s equity incentive plan and executive compensation, and the timeline for approval of executive compensation going forward. To view the full press releases, visit http://nnw.fm/Xf0Bs.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.832944, off by 1.43%, on 64,271 volume with 55 trades. The average volume for the last 3 months is 95,482 and the stock's 52-week low/high is $0.75/$2.24.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) was featured today in the 420 with CNW by CannabisNewsWire. As plans to legalize marijuana fully appear to have hit a dead end in the New York State legislature, the lawmakers have agreed to expand the decriminalization of the drug in addition to providing for the automatic expungement of low-level cannabis possession convictions across the state. On Thursday, Senators agreed to treat the possession of up to two ounces of cannabis as an infraction punishable by a $50 fine instead of regarding it as a crime. This measure marks a huge change in a state where thousands of residents have been caught on the wrong side of the law and been incarcerated.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed Monday's trading session at $0.2362, off by 8.02%, on 32,228 volume with 24 trades. The average volume for the last 3 months is 115,515 and the stock's 52-week low/high is $0.206/$0.605.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed Monday's trading session at $1.67, up 7.52%, on 15,363 volume with 26 trades. The average volume for the last 3 months is 17,707 and the stock's 52-week low/high is $0.10/$1.809.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Monday's trading session at $0.031, up 1.64%, on 616,345 volume with 38 trades. The average volume for the last 3 months is 1,639,744 and the stock's 52-week low/high is $0.697/$4.429.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.